-
Cancer Conference Attendees Told of Success with New Mesothelioma Treatment Approach
Attendees at the this year’s Annual Meeting of the American Association of Cancer Researchers were greeted with news that a new approach to treating advanced-stage solid tumors such as mesothelioma showed tremendous success in a phase I clinical trial. The research was conducted by Memial researchers at the renowned Memorial Sloan Kettering Cancer Center, who
-
Chinese Study Reveals Importance of Nutrition for Patients with Peritoneal Mesothelioma
Between malignant pleural mesothelioma and malignant peritoneal mesothelioma — the two most frequently-made mesothelioma diagnoses — peritoneal mesothelioma occurs far less frequently. Among the roughly 3,500 patients diagnosed with the deadly form of asbestos-related cancer in the United States each year, only about 700 have the tumors appear in their abdominal lining: almost all others
-
Johnson & Johnson Suddenly Settles Three Mesothelioma Lawsuits
In a notable departure from previous practice, consumer giant Johnson & Johnson suddenly settled three separate lawsuits filed by people who blamed the company’s popular talc-based products for their mesothelioma diagnosis. Prior to these agreements, which apparently closed within 24 hours of each other, the company has defended itself aggressively against charges of asbestos contamination
-
Mentally Disabled Woman’s Mesothelioma At the Heart of Most Recent Talc Baby Powder Lawsuit
A mesothelioma diagnosis would represent heartache, pain and suffering for anybody, but when the victim is already mentally disabled and has little understanding of what is happening to her, the tragedy is even greater. That is exactly what a California jury is hearing about today, as 36-year-old Gail Koretoff is pursuing legal action against Johnson
-
Mesothelioma Claims the Life of World Trade Center Worker’s Wife
A mesothelioma lawsuit currently making its way through the New York City Asbestos Litigation courts provides the perfect snapshot of how dangerous asbestos is. The case involves Mrs Albina Licul, a 73-year-old woman who was diagnosed with malignant pleural mesothelioma on May 11th, 2015. Mrs. Licul died exactly two months after being told that she
-
New Study to Test Dendritic Cell Immunotherapy Treatment on Mesothelioma
A Netherlands-based biotechnology company has announced progress on its phase II/III mesothelioma study, looking at the impact of its dendritic cell therapy on patients diagnosed with the rare and deadly asbestos-caused cancer. Amphera B.V.’s entire focus is on dendritic cell therapy, and is currently planning three different clinical trials: this is its first, which will
-
Study Examines Need for Additional Specialized Palliative Care for Mesothelioma Patients
A study conducted by researchers at Australia’s Curtin University has found that when it comes to treating patients diagnosed with malignant mesothelioma, early specialist palliative care provides no meaningful improvement in quality of life. Australian caregivers and scientists are particularly attuned to the needs of mesothelioma patients as, along with the United Kingdom, the nation
-
New Jersey Mesothelioma Lawsuit Against Johnson & Johnson Focuses on Dueling Mineral Experts
In defending themselves against charges of being responsible for Ricardo Rimondi’s malignant mesothelioma, attorneys for Johnson & Johnson’s Baby Powder are not arguing about whether asbestos causes the illness: they seem to have accepted that science. Rather, they are focusing on presenting the jury with confounding and often confusing testimony about what is or is
-
MIT Scientists Look to Deliver Mesothelioma Treatments in Inhalable Form
Mesothelioma is such a lethal condition, and so challenging to treat, that cancer researchers are being forced to think outside of the box to find both better medications and better ways to deliver those medications. Scientists from MIT’s Koch Center for Integrative Cancer Research are doing both, creating a specially-formulated medication that instructs the lung’s
-
New York Court of Appeals Decides for Mesothelioma Victim and Against Chevron
The family of a seaman who died of malignant mesothelioma has won the right to pursue legal action nearly two decades after he signed a release in a case he filed against Texaco for another asbestos-related illness. Mason South had worked as a merchant marine from 1945 to 1982, and during that time he worked
-
Mesothelioma Patient Included in Broader Immunotherapy Study
Malignant mesothelioma is among the rarest forms of cancer. It is also one of the most difficult to treat. Mesothelioma continues to be considered a fatal diagnosis, despite strides that have been made in improving longevity for many of those identified as having the disease. It is the challenge of treating the condition, as well
-
New Jersey Jury Hears of Impact of Man’s Malignant Mesothelioma
Ricardo Rimondi is one among many mesothelioma victims who are seeking compensation from Johnson & Johnson: he holds the company responsible because he believes they knew their popular baby powder was contaminated with asbestos and did nothing about it. This week a New Jersey jury listened to testimony from his family, speaking of the challenges
-
$29 Million Verdict in California Mesothelioma Lawsuit Against Johnson & Johnson
Today a California jury delivered a $29 million judgment against Johnson & Johnson, agreeing with a mesothelioma victim that the company’s iconic baby powder was the cause of her illness and that the company had been well aware of its dangers. Though the company has already indicated that they will appeal the decision, this outcome
-
Study Reveals 6 Characteristics of Longest-Surviving Mesothelioma Patients
Mesothelioma, the rare form of cancer caused by exposure to asbestos, has rightly earned the reputation of being one of the most challenging conditions to treat: despite years of research and the introduction of innovative treatment protocols, the illness continues to be viewed as always fatal, with a median survival time of less than two
-
Jury Begins Deliberations In California Johnson & Johnson Mesothelioma Trial
Monday saw closing arguments in a California courtroom, where the jury is being asked to decide whether asbestos in Johnson & Johnson’s baby powder is responsible for a woman’s mesothelioma diagnosis. The Oakland, California trial is just the latest in a series that accuses the company of knowing that its iconic and trusted product was
-
Funding for Research Into Cancers Like Mesothelioma Is Falling
There have been remarkable breakthroughs in the science surrounding malignant mesothelioma in the last several years. We now know far more about how the cancerous tumors form, what role asbestos plays on changes in cell DNA, and the impact of various advanced treatment technologies on the tumors and on patient survival. Unfortunately, at the same
-
Elderly Man Tracks His Mesothelioma to College Asbestos Exposure
Malignant pleural mesothelioma is known for many things: the condition is caused by exposure to asbestos, is always considered fatal, and has a remarkably long latency period. Though the path of this rare form of cancer is still not completely understood, what we do know is that it is caused by breathing in asbestos fibers,
-
Will FDA Act to Protect Consumers from Mesothelioma Risk from Cosmetic Products?
In the early 20th century, few were aware of asbestos-related diseases like mesothelioma. In the years since, American workers, veterans and consumers have been diagnosed with the disease, and the public has become far more aware of the risk posed by exposure to the carcinogenic material. Asbestos product companies have been found liable for illnesses
-
Interior Designer’s Mesothelioma Claim Highlights Many Ways Asbestos Exposure Occurs
When sixty-year-old Allison Linsky set out to be an interior designer, she had no idea that it would lead to her eventual diagnosis with malignant mesothelioma. But according to her lawsuit against American Biltrite, Inc., that is exactly what happened. Linsky was diagnosed with the rare and deadly form of cancer in April of 2016,
-
New Jersey’s Bid to Stop Mesothelioma: Lawmakers Approve State Ban on Asbestos
In a time when partisanship has taken over much of our lives, diseases like malignant mesothelioma don’t discriminate between red states and blue states. The same can’t be said for decisions about what to do with the deadly material that causes mesothelioma. Republican-led administrations lean toward industry-friendly laws and fewer regulations, and the Trump administration
